| [1] |
Shi S, Tang Y, Zhao Q, et al. Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiology study[J/OL] The Lancet Regional Health - Western Pacific, 2022,(2022-04-11)[2022-06-10]. Available online 11 April 2022].
URL
|
| [2] |
Stoddard MF, Dawkins PR, Prince CR, et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study[J]. J Am Coll Cardiol, 1995, 25(2):452-459.
|
| [3] |
Lip GY, Hammerstingl C, Marin F, et al. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)[J]. Am Heart J, 2016, 178:126-134.
|
| [4] |
Madden JL. Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli[J]. J Am Med Assoc, 1949, 140(9):769-772.
|
| [5] |
Chao TF, Lin YJ, Tsao HM, et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation[J]. J Am Coll Cardiol, 2011, 58(23):2380-2385.
|
| [6] |
Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience[J]. Circulation, 2002, 105(16):1887-1889.
|
| [7] |
Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial[J]. Lancet, 2009, 374(9689):534-542.
|
| [8] |
Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial[J]. Circulation, 2013, 127(6):720-729.
|
| [9] |
Reddy VY, Möbius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)[J]. J Am Coll Cardiol, 2013, 61(25):2551-2556.
|
| [10] |
Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial[J]. J Am Coll Cardiol, 2014, 64(1):1-12.
|
| [11] |
中国医师协会心血管内科医师分会结构性心脏病专业委员会. 中国经导管左心耳封堵术临床路径专家共识[J]. 中国介入心脏病学杂志, 2019, 27(12):661-672.
|
| [12] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会, 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动:目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志, 2022, 26(1):15-88.
|
| [13] |
Kavinsky CJ, Kusumoto FM, Bavry AA, et al. SCAI/ACC/HRS institutional and operator requirements for left atrial appendage occlusion[J]. Heart Rhythm, 2016, 13(5):e241-e250.
|
| [14] |
Guérios EE, Schmid M, Gloekler S, et al. Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation[J]. Arq Bras Cardiol, 2012, 98(6):528-536.
|
| [15] |
Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience[J]. Catheter Cardiovasc Interv, 2012, 79(5):794-800.
|
| [16] |
陈良龙, 陆林祥, 方军, 等. 无需全身麻醉、经胸超声心动图引导的改良经皮左心耳封堵术的初步经验[J]. 中国介入心脏病学杂志, 2017, 25(6):326-330.
|
| [17] |
Zhang X, Jin Q, Kong D, et al. Comparison of fluoroscopy and transesophageal echocardiogram for intra-procedure device surveillance assessment during implantation of Watchman[J]. Int J Cardiol, 2021, 324:72-77.
|